Adenosine-mediated early preconditioning in mouse: Protective signaling and concentration dependent effects

Cardiovascular Research

Volumn 58, Issue 3, 2003, Pages 589-601

  Peart, Jason ^a   Headrick, John P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Experimental; Heart; Organ; Pathophysiology

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE; CHELERYTHRINE; LACTATE DEHYDROGENASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART STIMULATION; HEART VENTRICLE PRESSURE; INFUSION; ISOLATED HEART; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE DIPHOSPHATE; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CALCIUM CHANNEL BLOCKERS; DECANOIC ACIDS; DIAZOXIDE; ENZYME INHIBITORS; HYDROXY ACIDS; HYPOXANTHINE; INOSINE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NECROSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERFUSION; PHENANTHRIDINES; PHENETHYLAMINES; POTASSIUM CHANNELS; PROTEIN KINASE C; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; XANTHINE;

EID: 0038545554     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00259-1     Document Type: Article

References (49)

1. Liu Y., Sato T., O'Rourke B., Marban E. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation. 97:1998;2463-2469.
2. ATP channels and actin cytoskeleton. Am J Physiol Heart Circ Physiol. 276:1999;H1361-H1368.
3. + channel. J Mol Cell Cardiol. 29:1997;175-182.
4. 1 adenosine receptors. Am J Physiol Heart Circ Physiol. 279:2000;H1690-H1697.
5. ATP channels. Circ Res. 89:2001;273-278.
6. ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 87:2000;460-466.
7. ATP channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J Mol Cell Cardiol. 33:2001;831-834.
8. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol. 280:2001;H246-H255.
9. ATP channel. Am J Physiol Heart Circ Physiol. 42:1997;H847-H853.
10. ATP channel enhances adenosine-induced cardioprotection. Biochem J. 336:1998;337-343.
11. Fryer R.M., Schultz J.J., Hsu A.K., Gross G.J. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol Heart Circ Physiol. 276:1999;H1229-H1235.
12. Vahlhaus C., Schulz R., Post H., Rose J., Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol. 30:1998;197-209.
13. + channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res. 85:1999;731-741.
14. Yao Z.H., McPherson B.C., Liu H.P., et al. Signal transduction of flumazenil-induced preconditioning in myocytes. Am J Physiol Heart Circ Physiol. 280:2001;H1249-H1255.
15. Friehs I., Cao-Danh H., Takahashi S., et al. Adenosine prevents protein kinase C activation during hypothermic ischemia. Circulation. 96:(Suppl II):1997;221-226.
16. Lochner A., Marais E., Genade S., Moolman J.A. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol. 279:2000;H2752-H2765.
17. Bell R.M., Yellon D.M. The contribution of endothelial nitric oxide synthase to early ischemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res. 52:2001;274-280.
18. Woolfson R.G., Patel V.C., Neild G.H., Yellon D.M. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 91:1995;1545-1551.
19. Nakano A., Liu G.S., Heusch G., Downey J.M., Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 32:2000;1159-1167.
20. Gao F., Christopher T.A., Lopez B.L., et al. Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol Heart Circ Physiol. 279:2000;H329-H338.
21. 2A receptor in the modulation of myocardial reperfusion damage. J Cardiovasc Pharmacol. 33:1999;883-893.
22. 2 receptor-induced cardioprotection in guinea pig hearts. J Mol Cell Cardiol. 33:2001;2047-2053.
23. Takeishi Y., Huang Q., Wang T., et al. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning. J Mol Cell Cardiol. 33:2001;1989-2005.
24. ATP channels in adenosine-enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol. 279:2000;H2694-H2703.
25. ATP channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol. 279:2000;H2350-H2359.
26. Wang G.Y., Wu S., Pei J.M., Yu X.C., Wong T.M. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol. 280:2001;H384-H391.
27. Headrick J.P., Peart J., Hack B., Flood A., Matherne G.P. Functional properties and responses to ischemia reperfusion in Langendorff perfused mouse hearts. Exp Physiol. 86:2001;703-716.
28. 1 adenosine receptors during ischemia and reperfusion improves ischemic tolerance. Am J Physiol Heart Circ Physiol. 279:2000;H2166-H2175.
29. 1 adenosine receptors mimics ischemic preconditioning. Am J Physiol Heart Circ Physiol. 279:2000;H1071-H1078.
30. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol. 30:1998;579-585.
31. Parsons M., Young L., Lee J.E., Jacobson K.A., Liang B.T. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J. 14:2000;1423-1431.
32. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res. 88:2001;520-528.
33. Stepp D.W., Van Bibber R., Kroll K., Feigl E.O. Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res. 79:1996;601-610.
34. Bolling S.F., Olszanski D.A., Childs K.F., Gallagher K.P., Ning X.H. Stunning, preconditioning, and functional recovery after global myocardial-ischemia. Ann Thorac Surg. 58:1994;822-827.
35. Xi L., Hess M.L., Kukreja R.C. Ischemic preconditioning in isolated perfused mouse heart: Reduction in infarct size without improvement of post-ischemic ventricular function. Mol Cell Biochem. 186:1998;69-77.
36. Yang X.-M., Sato H., Downey J.M., Cohen M.V. Protection of ischemic preconditioning is dependent upon a critical sequence of protein kinase C activation. J Mol Cell Cardiol. 29:1997;991-999.
37. Liu H., McPherson B.C., Zhu X., et al. Role of nitric oxide and protein kinase C in ACh-induced cardioprotection. Am J Physiol Heart Circ Physiol. 281:2001;H191-H197.
38. ATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol Heart Circ Physiol. 277:1999;H2425-H2434.
39. Imamura G., Bertelli A.A., Bertelli A., et al. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol. 282:2002;H1996-H2003.
40. Dorn G.W., Souroujon M.C., Liron T., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci USA. 96:1999;12798-12803.
41. Saurin A.T., Pennington D.J., Raat N.J.H., et al. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res. 55:2002;672-680.
42. Puett D.W., Forman M.B., Cates C.U., et al. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation. 76:1987;678-686.
43. Vanden Hoek T.L., Becker L.B., Shao Z.H., Li C.Q., Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 86:2000;541-548.
44. Gelpi R.J., Morales C., Cohen M.V., Downey J.M. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol. 97:2002;40-46.
45. Peart J., Matherne G.P., Cerniway R.J., Headrick J.P. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Cardiovasc Res. 52:2001;120-129.
46. Becker B.F., Reinholz N., Ozcelik T., Leipert B., Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pfluger's Arch. 415:1989;127-135.
47. Das D.K., Engelman R.M., Clement R., et al. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun. 148:1987;314-319.
48. Hopson S.B., Lust R.M., Sun Y.S., et al. Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model. J Nat Med Assoc. 87:1995;480-484.
49. Ekelund U.E.G., Harrison R.W., Shokek O., et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res. 85:1999;437-445.